Quantinno Capital Management LP raised its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 81.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 106,464 shares of the real estate investment trust's stock after acquiring an additional 47,931 shares during the period. Quantinno Capital Management LP's holdings in Omega Healthcare Investors were worth $4,333,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. raised its position in shares of Omega Healthcare Investors by 353.4% in the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 516 shares during the last quarter. True Wealth Design LLC acquired a new position in shares of Omega Healthcare Investors in the 3rd quarter valued at $31,000. DiNuzzo Private Wealth Inc. acquired a new stake in Omega Healthcare Investors during the 3rd quarter worth about $33,000. V Square Quantitative Management LLC grew its stake in Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock valued at $40,000 after purchasing an additional 323 shares during the last quarter. Finally, Truvestments Capital LLC acquired a new position in shares of Omega Healthcare Investors in the third quarter valued at about $43,000. 65.25% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Omega Healthcare Investors
In other news, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.
Omega Healthcare Investors Price Performance
OHI stock traded down $0.01 during trading on Monday, hitting $39.24. The stock had a trading volume of 1,531,578 shares, compared to its average volume of 1,683,967. The company's 50-day moving average price is $40.48 and its two-hundred day moving average price is $37.69. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $44.42. The stock has a market capitalization of $10.59 billion, a P/E ratio of 28.86, a PEG ratio of 1.22 and a beta of 0.98. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48.
Omega Healthcare Investors Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.83%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's payout ratio is 197.06%.
Analysts Set New Price Targets
OHI has been the subject of several research analyst reports. Truist Financial lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. Mizuho raised their target price on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a report on Thursday. Royal Bank of Canada upped their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a report on Monday, November 11th. Wells Fargo & Company reissued an "overweight" rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Finally, BMO Capital Markets raised shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 target price for the company in a report on Monday. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $40.18.
View Our Latest Stock Report on Omega Healthcare Investors
Omega Healthcare Investors Profile
(
Free Report)
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Featured Stories
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.